Mesa Laboratories Inc (MLAB) Financial Statements
Industry: Industrial Instruments For Measurement, Display, and Control
In fiscal 2026, Mesa Laboratories reported revenue of $249.1M, up 3.4% from $241.0M the year before. Net income was $6.7M (a 2.7% net margin), or $1.21 per diluted share. Gross margin was 63.5% and operating margin was 7.4%. Operating activities generated $42.8M of cash, leaving $39.6M of free cash flow. At fiscal year end, Mesa Laboratories held $427.7M in total assets against $241.5M in total liabilities, including $26.9M of cash and equivalents.
Open the full interactive Mesa Laboratories financials → Quarterly statements, key ratios, valuation history and price charts.
Mesa Laboratories Key Stats
| Share Price | $127.56 |
|---|---|
| Market Cap | $734.4M |
| P/E Ratio | 105.4 |
| Dividend Yield | 0.48% |
| Revenue YoY Growth | +3.4% |
| 52-Week Range | $67.88 – $142.23 |
| Shares Outstanding | 5.7 million (basic, 2027 Q1) |
Mesa Laboratories Income Statement
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | FY 2026 | |
|---|---|---|---|---|---|---|
| Revenue | $133.9M | $184.3M | $219.1M | $216.2M | $241.0M | $249.1M |
| Gross Profit | $87.0M | $109.1M | $133.7M | $133.2M | $150.9M | $158.3M |
| Operating Income | $12.4M | $4.7M | $3.3M | -$272.1M | $16.3M | $18.5M |
| Pre-Tax Income | $2.3M | $3.6M | -$389,000 | -$275.6M | $6.0M | $12.0M |
| Income Tax | -$971,000 | $1.7M | -$1.3M | -$21.4M | $7.9M | $5.3M |
| Net Income | $3.3M | $1.9M | $930,000 | -$254.2M | -$2.0M | $6.7M |
| Diluted EPS | $0.64 | $0.35 | $0.17 | -$47.20 | -$0.36 | $1.21 |
Mesa Laboratories Quarterly Results
| 2026 Q2 | 2026 Q3 | 2026 Q4 | 2027 Q1 | |
|---|---|---|---|---|
| Revenue | $60.7M | $65.1M | $63.7M | $60.1M |
| Net Income | $2.5M | $3.6M | -$4.1M | $2.8M |
| Diluted EPS | $0.45 | $0.65 | -$0.74 | $0.49 |
Mesa Laboratories Balance Sheet
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | FY 2026 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | $263.9M | $49.3M | $32.9M | $28.2M | $27.3M | $26.9M |
| Current Assets | $303.7M | $124.3M | $119.0M | $109.4M | $102.7M | $106.3M |
| Total Assets | $601.5M | $707.4M | $661.8M | $446.8M | $433.3M | $427.7M |
| Current Liabilities | $32.6M | $48.1M | $43.4M | $44.3M | $164.0M | $61.9M |
| Total Long-Term Debt | $145.7M | $218.4M | $183.3M | $221.7M | $71.2M | $67.5M |
| Total Liabilities | $195.2M | $313.6M | $268.4M | $301.4M | $273.5M | $241.5M |
| Shareholders' Equity | $406.2M | $393.8M | $393.5M | $145.4M | $159.8M | $186.2M |
Mesa Laboratories Cash Flow Statement
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | FY 2026 | |
|---|---|---|---|---|---|---|
| Cash From Operations | $37.1M | $39.2M | $28.0M | $44.1M | $46.8M | $42.8M |
| Cash From Investing | -$2.0M | -$305.2M | -$9.5M | -$81.3M | -$4.5M | -$3.2M |
| Cash From Financing | $146.2M | $52.6M | -$33.3M | $32.8M | -$44.5M | -$41.9M |
| Free Cash Flow | $35.1M | $34.8M | $23.4M | $41.6M | $42.6M | $39.6M |
| Dividends Paid | $3.2M | $3.3M | $3.4M | $3.4M | $3.5M | $3.5M |
Figures from Mesa Laboratories' 10-K and 10-Q filings with the SEC, as of 2026-10-14. Fiscal years follow the company's own reporting calendar. EPS and share counts are adjusted for later stock splits. See the full Mesa Laboratories financials page for every line item.
Mesa Laboratories Company Profile
| Ticker | MLAB |
|---|---|
| Exchange | Nasdaq |
| Industry | Industrial Instruments For Measurement, Display, and Control |
| Headquarters | Lakewood, Colorado |
| Incorporated in | Colorado |
| Fiscal Year End | March 31 |
| SEC Filer Category | Accelerated filer |
| SEC CIK | 0000724004 |
Frequently Asked Questions
What was Mesa Laboratories' revenue in fiscal 2026?
Mesa Laboratories (MLAB) reported revenue of $249.1M for fiscal 2026.
What is Mesa Laboratories' annual revenue history?
Mesa Laboratories' annual revenue by fiscal year: 2021: $133.9M; 2022: $184.3M; 2023: $219.1M; 2024: $216.2M; 2025: $241.0M; 2026: $249.1M.
What was Mesa Laboratories' net income in fiscal 2026?
Mesa Laboratories reported net income of $6.7M for fiscal 2026.
What was Mesa Laboratories' earnings per share (EPS) in fiscal 2026?
Mesa Laboratories' diluted EPS was $1.21 for fiscal 2026 (adjusted for any later stock splits).
How much free cash flow did Mesa Laboratories generate in fiscal 2026?
Mesa Laboratories generated $39.6M of free cash flow in fiscal 2026.
What was Mesa Laboratories' revenue last quarter?
In its most recent reported quarter (2027 Q1), Mesa Laboratories reported revenue of $60.1M.
How much debt does Mesa Laboratories have?
Mesa Laboratories reported $67.5M of long-term debt, including the current portion, at the end of fiscal 2026.
How many shares of Mesa Laboratories are outstanding?
Mesa Laboratories reported a weighted average of 5.7 million basic shares outstanding in 2027 Q1.
What is Mesa Laboratories' market cap?
Based on its latest closing price, Mesa Laboratories (MLAB) has a market capitalization of about $734.4M.
When does Mesa Laboratories' fiscal year end?
Mesa Laboratories' fiscal year end, as registered with the SEC, is March 31.
Where is Mesa Laboratories headquartered?
Mesa Laboratories lists its business address in Lakewood, Colorado in its SEC filings.